CDEK
← All trials

NCT02973087

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date
Nov 1, 2016
Primary completion
Mar 1, 2018
Completion date
Mar 1, 2018
First posted
—
Last posted
—
Enrollment
18
Arms / groups
1 / —
Source
AACT · pre-existing

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.